SCHEMBL802973

SCHEMBL802973

CC1CCCCc2cc(C(=O)C(C)(C)C)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
ALOX5 P09917 1/20 0.37
SMYD3 Q9H7B4 1/20 0.35
DHODH Q02127 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
HTT P42858 2/20 0.34
HDAC6 Q9UBN7 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
PDE4D Q08499 1/20 0.34
KDM2B Q8NHM5 3/20 0.33
GRM1 Q13255 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL802967 0.96 ALDH1A1 (0.39) ALDH1A1ALOX5SMYD3DHODHMAPT
SCHEMBL803409 0.90 ALOX5 (0.36) ALDH1A1ALOX5MAPTHPGDHDAC6
SCHEMBL803351 0.90 ALOX5 (0.36) ALDH1A1ALOX5MAPTHPGDHDAC6
SCHEMBL802978 0.90 ALOX5 (0.36) ALDH1A1ALOX5MAPTHPGDHDAC6
SCHEMBL803415 0.89 ALDH1A1 (0.38) ALDH1A1ALOX5SMYD3DHODHMAPT
SCHEMBL802970 0.84 ALDH1A1 (0.39) ALDH1A1ALOX5MAPTHTTHDAC6
SCHEMBL19495252 0.80 CHRNB2 (0.45) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL9055964 0.79 ALDH1A1 (0.54) ALDH1A1MAPTHTTLMNASMN1; SMN2
SCHEMBL20652081 0.78 ALDH1A1 (0.61) ALDH1A1SMYD3MAPTHPGDHTT
SCHEMBL25195403 0.78 AKR1C3 (0.44) ALDH1A1MAPTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 ALDH1A1 1267/4885ALOX5 2016/4885SMYD3 2447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.